News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Onyvax Limited Release: Phase IIb Clinical Trial Of Onyvax-P In Early Stage Prostate Cancer Initiated In United States


9/28/2007 11:29:37 AM

London, UK, 26 September 2007: Onyvax Ltd, the biotechnology company developing novel cancer therapies, announced today that a Phase IIb clinical trial with Onyvax-P, designed to stimulate the immune system to fight prostate cancer, is now underway at the National Cancer Institute, Bethesda, Maryland.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES